Navigation Links
Gene Test Could Boost Myeloma Treatment
Date:9/20/2007

Certain DNA influences who'll respond best to therapy, scientists say

THURSDAY, Sept. 20 (HealthDay News) -- Analyzing the activity of a small subset of genes may help identify patients with the worst cases of multiple myeloma, U.S. researchers say.

It may also help guide their treatment, noted the team from the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences.

Multiple myeloma is a cancer that affects the blood plasma cells in bone marrow that produce antibodies. There is wide variation in how well multiple myeloma patients respond to treatment.

This study included 532 patients who were followed for seven years after they had a blood stem cell transplant. The researchers created a genetic profile of each patient to chart the severity of their multiple myeloma.

They found that the activity of as few as 17 genes could determine whether a patient was at high or low risk for a poor prognosis.

The findings were to be presented this week at an American Association for Cancer Research conference in Atlanta.

"There are enormous differences between how different people fare with multiple myeloma. While most do very well, others have a highly aggressive form of the disease, and this is not recognized well with current prognostic variables," lead researcher John D. Shaughnessy Jr., a professor of medicine at the Myeloma Institute for Research and Therapy, said in a prepared statement.

"If we can categorize a patient's risk early, we can better guide that patient toward therapies that might be more effective for them based on the genetic profile of the disease," he explained.

More information

The American Cancer Society has more about multiple myeloma.



-- Robert Preidt



SOURCE: American Association for Cancer Research, news release, Sept. 18, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Beware of the oral patch! It could be cancer!!!
5. Low Birth Weight infants could have Problems in the Future
6. False beliefs could cost cancer patients their lives
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Prozac miracle could end in disaster
9. Wonder drug - could end in disaster
10. Pollution could be a risk
11. Fright could be more harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission for Health ... Association (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction in Oncology. ... distinction. ACHC provides a wide range of pharmacy accreditation services that assess the ...
(Date:4/28/2016)... ... April 28, 2016 , ... SyncDog, Inc. , ... leading secure mobility workstation suite, SentinelSecure™, at MobileIron’s 6th annual Mobile First Conference ... will be MobileIron’s 6th Mobile First Conference and will feature immersive training, collaboration, ...
(Date:4/28/2016)... ... ... Baich had written poetry dating back to her childhood, but after several years without writing ... on a more spiritual tone. The desire to put the words on paper was very ... file it away. Friends would ask her how she wrote such wonderful poetry and her ...
(Date:4/28/2016)... ... , ... For the 10,000 Americans who turn 65 on any given day, ... well-being: mental health. Now, a new book—Staying Sharp For Dummies (Paper; ISBN: 978-1-119-18779-0; Available ... can include everything from honing your memory and managing stress to eating healthy foods ...
(Date:4/28/2016)... ... ... Boston Laser is now offering a novel treatment for Keratoconus following its approval ... of Riboflavin, a vitamin, to the cornea. This, combined with UV light, leads to ... the progression of keratoconus. , Keratoconus is the continuous thinning and alteration of the ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016 ... a developer of a new generation of drugs ... overall survival results for Paclical/Apealea in the Phase ... patients with epithelial ovarian cancer. These preliminary results ... in combination with carboplatin versus Taxol in combination ...
(Date:4/27/2016)... SAN FRANCISCO , April 27, 2016 /PRNewswire/ ...  is expected to reach USD 2.06 billion by ... View Research, Inc. Increasing consumer awareness towards a ... over the next seven years.      ... Improper diet intake coupled with rising health treatment ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, ... of Jennifer Hagerman , Pharm D., to Vice ... growing role at Diplomat, Hagerman will continue to lead ... company that delivers custom education and training to Diplomat ... specialty pharmacy industry. Diplomat University also houses the quality ...
Breaking Medicine Technology: